CDER Adds Gaucher Disease to 2017 Guidance Agenda Post author:Sam Post published:April 20, 2017 Post category:Drug Industry Daily CDER updated its guidance agenda for 2017, adding an item on Gaucher Disease. Source: Drug Industry Daily You Might Also Like FDA Places Divi’s Facility on Import Alert March 27, 2017 European Commission Finds Fewer Pay-for-Delay Deals March 13, 2018 Two Years After Winning Accelerated Approval, GSK Pulls Blenrep At FDA’s Request November 22, 2022
